Although there was a significant effect on the secondary endpoint of executive dysfunction, there was no improvement in the primary cognitive endpoint or in activities of daily living.154 Therefore, currently, there is no clinical indication for cholinesterase inhibitors and memantine in poststroke cognitive impairment or vascular dementia, although they can be used in cases of suspected mixed dementia with co-existent AD. Here, BCHE is linked to vascular dementia.